WEDNESDAY, April 8 (HealthDay News) — The troubled psoriasis drug Raptiva is life withdrawn from the U.S. market, California-based drug maker Genentech announced Wednesday.
The go comes nearly two months after U.S. shape officials issued a public shape advisory on the drug after confirming a link to a rare, sometimes fatal brain infection.
In a prepared release, [...]



Recent Comments